Information Provided By:
Fly News Breaks for August 7, 2018
ALXN
Aug 7, 2018 | 07:14 EDT
Stifel transferred coverage of Alexion to analyst Paul Matteis, who set a Hold rating and $130 price target on the shares, down from the firm's prior Buy rating. He has difficulty envisioning significant upside to mid-to-long-term consensus expectations given his worries about the risks associated with an increasingly challenging European payor environment and the breadth of drug development ongoing in the complement space, Matteis tells investors.
News For ALXN From the Last 2 Days
There are no results for your query ALXN